The Role of Breastfeeding in Postpartum Disease Activity in Women with Inflammatory Bowel Disease

Kane, Sunanda; Lemieux, Nicole
January 2005
American Journal of Gastroenterology;Jan2005, Vol. 100 Issue 1, p102
Academic Journal
BACKGROUND: Women with inflammatory bowel disease (IBD) have an increased risk of experiencing a flare in the postpartum period. Work in other autoimmune disorders has found that breastfeeding may be associated with an increased risk for developing postpartum disease relapse.AIM: To assess the association between breastfeeding behavior and postpartum disease activity.METHODS: Women with IBD followed at a tertiary care center with a history of childbirth within the past 5 yr were recruited. Medical records were reviewed for disease type, disease activity during and after pregnancy, medication use, smoking, and breastfeeding behavior. The exposure of interest was breastfeeding prior to the onset of disease activity following a successful asymptomatic pregnancy.RESULTS: One hundred and twenty-two consecutive women who fit eligibility criteria were studied. Overall, only 44% (54/122) of the women had breastfed their infant. Reasons included physician recommendation, fear of medication interactions, and personal choice. Forty-three percent (23/54) of those who breastfed experienced a postpartum flare of their disease. The unadjusted odds ratio for disease activity with a history of breastfeeding was 2.2 (95% CI 1.2–3.9,p= 0.004). When stratified by disease type, the OR for ulcerative colitis was 0.89 (0.29–2.7,p>0.05) and Crohn's disease 3.8 (1.9–7.4,p<0.05). When adjusted for medication cessation, the OR became nonsignificant.CONCLUSIONS: A significant number of women with IBD do not breastfeed their children. Any relationship between breastfeeding and disease activity may be more a consequence of discontinuation of IBD therapies.(Am J Gastroenterol 2005;100:102–105)


Related Articles

  • An Investigation of Genome-Wide Studies Reported Susceptibility Loci for Ulcerative Colitis Shows Limited Replication in North Indians. Juyal, Garima; Prasad, Pushplata; Senapati, Sabyasachi; Midha, Vandana; Sood, Ajit; Amre, Devendra; Juyal, Ramesh C.; BK, Thelma // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Genome-Wide Association studies (GWAS) of both Crohn's Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40 risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously associated with UC or CD susceptibility in populations of...

  • Hydroxylases as therapeutic targets in inflammatory bowel disease. Cummins, Eoin P.; Doherty, Glen A.; Taylor, Cormac T. // Laboratory Investigation (00236837);Apr2013, Vol. 93 Issue 4, p378 

    Inflammatory bowel disease (IBD) is a common and debilitating clinical disorder comprising ulcerative colitis and Crohn disease. IBD occurs when inappropriate immunological activity in the intestinal mucosa results in epithelial barrier dysfunction leading to exposure of the mucosal immune...

  • Crohn's disease in a Meckel's diverticulum: report of a case. Diamond, Ivan R.; Hayes-Jordan, Andrea; Phillips, M. James; Langer, Jacob C. // Pediatric Surgery International;Mar2008, Vol. 24 Issue 3, p361 

    Meckel's diverticulum has previously been reported to be present in patients with Crohn's disease. However, the finding is typically an incidental one, and involvement of the diverticulum in the disease process is uncommon. We report a case of an adolescent with known Crohn's disease who...

  • Role of capsule endoscopy Pillcam COLON 2 in patients with known or suspected Crohn's disease who refused colonoscopy or underwent incomplete colonoscopic exam: a case series. Negreanu, L.; Smarandache, G.; Mateescu, R. // Techniques in Coloproctology;Mar2014, Vol. 18 Issue 3, p277 

    Background: Almost 70-80 % of patients with Crohn's disease and virtually all patients with ulcerative colitis have colorectal mucosa involvement. Colon capsule endoscopy is an interesting option for patients unable or unwilling to undergo colonoscopy. We report our experience with the...

  • Indications for and results of operation in inflammatory bowel disease. Schofield, P. F.; Manson, J. M. // Journal of the Royal Society of Medicine;Oct1986, Vol. 79 Issue 10, p593 

    Of 363 patients with inflammatory bowel disease presenting between 1972 and 1983, 166 required definitive operation. A classification by histological type distinguishes Crohn's disease (CD) from ulcerative colitis (UC) and indeterminate inflammatory bowel disease. CD is divided into...

  • Incidence idiopatických stÅ™evních zánÄ›tů u dÄ›tí a dospívajících v Plzeňském kraji v letech 2001-2011 Prospektivní studie. Schwarz, J.; Sýkora, J. // Czecho-Slovak Pediatrics / Cesko-Slovenska Pediatrie;2013, Vol. 68 Issue 3, p149 

    The objective of the work was to verify the incidence of idiopathic bowel disease (IBD) inflammations in the Plzeň Region (PLK) in children up to 19 years old and to determine, whether there are any geographic or demographic differences in their incidence in a precisely defined area of PLK....

  • Forms of IBD have distinctive features.  // New Zealand Doctor;2/10/2010, p20 

    The article presents information on the forms of inflammatory bowel diseases and their features. It notes that there is a difference between the inflammation of Crohn's disease and ulcerative colitis. Gross dilatation of the colon may occur in a person suffering from severe fulminant colitis...

  • Utilization of Health-Care Resources by Patients With IBD in Manitoba: A Profile of Time Since Diagnosis. Longobardi, Teresa; Bernstein, Charles N. // American Journal of Gastroenterology;Aug2007, Vol. 102 Issue 8, p1683 

    OBJECTIVES: We tested the hypothesis of nonlinear longitudinal trends in health-care utilization by individuals with Crohn's disease (CD) and ulcerative colitis (UC) in Manitoba. METHODS: Administrative databases were used to report resource use in 2000/1. A total of 5,485 cases of CD and UC and...

  • Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Straub, R. H.; Grum, F.; Strauch, U.; Capellino, S.; Bataille, F.; Bleich, A.; Faik, W.; Scholmerich, J.; Obermeier, F. // Gut;Jul2008, Vol. 57 Issue 7, p911 

    Background: Substance P (SP) is a pro-inflammatory neuropeptide in colitis, whereas sympathetic neurotransmitters are anti-inflammatory at high concentrations. Aim and methods: In all layers of the colon, nerve fibre densities of SP+ and sympathetic nerve fibres were investigated (22 Crohn's...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics